Quantcast

Sign Up For Email Updates:

       Please leave this field empty

From Our Blog

More from the blog »
WCRF/AICR
Global Network

Growth Inhibition of Prostate Cancer Cell by Selenomethionine Through MAP Kinase Signaling (2005)

Title:

Growth Inhibition of Prostate Cancer Cell by Selenomethionine Through MAP Kinase Signaling

Key words:

Selenium, ERK1/2 signalling pathway

Research Institution:

University of Arizona

Location:

Arizona

Researcher:

Durga Prasad P Cherukuri

Project Description:

This post-doctoral study sought to understand the role that the ERK1/2 signalling pathway plays in growth inhibition of androgen-sensitive and insensitive prostate cancer cells (LNCaP and DU145). The study also examined ERK1/2 pathway proteins as markers of the clinical effcacy of selenium in patients treated on a selenium supplementation trial for prostate cancer.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note